Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1458, 2004-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Canadian Aredia/Zometa product monographs add osteonecrosis
Reactions Weekly, Vol. 1, Iss. 1033, 2005-01 ,pp. :
Risk of torsade de pointes leads to labelling change for dolasetron
Reactions Weekly, Vol. 1, Iss. 1333, 2011-01 ,pp. :
Mesoridazine labelling changed in the US
Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. :
Levacetylmethadol labelling strengthened in the US
Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. :
Zafirlukast labelling revised in the US
Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. :